Prof. Dr. Martin Lambert

Special member of the EAOF board, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Prof. Dr. Martin Lambert

Special member of the EAOF board, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Biography

Professor Martin Lambert, M.D., performed his psychiatric training at the Department of Psychiatry and Psychotherapy at the University Medical Center in Hamburg, Germany. During his training, Dr Lambert spent two years at the Early Psychosis Prevention and Intervention Centre (EPPIC) as a Research Fellow of the University of Melbourne. He is a Professor of Psychiatry at the University of Hamburg where he heads to Psychosis Centre including Integrated Care and the Early Detection and Intervention Centre. He is the Senior Teaching Lecturer of the Department and Deputy Speaker of the Hamburg Network of Psychic Health. Dr Lambert’s current research interests include the pharmacological treatment of schizophrenia and first-episode psychosis patients, and, especially, aspects of integrated care, remission and recovery, quality of life and subjective wellbeing. He has been editor and author of several books about schizophrenia and published articles in various research fields in schizophrenia, first-episode psychosis and integrated care.

Potential conflicts of interest: Receipt of grants/research supports: AstraZeneca, Lilly Deutschland GmbH, Janssen Cilag GmbH, Lundbeck GmbH, Otsuka Pharma GmbH, Sanovi Aventis. Receipt of honoraria or consultation fees: AstraZeneca, Bristol-Myers Squibb, Lilly Deutschland GmbH, Janssen Cilag GmbH, Lundbeck GmbH, Otsuka Pharma GmbH, Roche Deutschland Holding GmbH, Sanovi Aventis Participation in a company sponsored speaker’s bureau: None Stock shareholder: None Spouse/partner: None Other support (please specify): None